Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Biocryst Pharmaceuticals 

2190 Parkway Lake Drive

Birmingham  Alabama  35244  U.S.A.
Phone: 205-444-4600 Fax:




Affinimark Technologies Inc. 

 Company News
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of BCX4430 To Treat Hemorrhagic Fever Virus Diseases 8/13/2014 7:20:58 AM
Biocryst Pharmaceuticals (BCRX) Reports Second Quarter 2014 Financial Results 8/5/2014 7:56:35 AM
Biocryst Pharmaceuticals (BCRX) To Announce Second Quarter 2014 Financial Results August 5 7/22/2014 3:22:34 PM
Biocryst Pharmaceuticals (BCRX) Announces Exercise Of Over-Allotment Option And Completion Of Public Offering 6/3/2014 10:52:18 AM
Biocryst Pharmaceuticals (BCRX) Prices Public Offering Of Common Stock 5/29/2014 9:07:57 AM
Biocryst Pharmaceuticals (BCRX) Commences Public Offering Of Common Stock 5/28/2014 9:03:16 AM
Biocryst Pharmaceuticals (BCRX) Announces Positive Results From Opus-1, A Phase 2 Trial Of BCX4161 For The Prophylactic Treatment Of Hereditary Angioedema 5/27/2014 9:03:06 AM
Biocryst Pharmaceuticals (BCRX) To Announce Results From The BCX4161 Opus-1 Phase 2 Trial For Hereditary Angioedema May 27 5/27/2014 8:57:14 AM
Biocryst Pharmaceuticals (BCRX) To Present At Bank of America (BAC) Merrill Lynch 2014 Healthcare Conference 5/9/2014 9:52:02 AM
Biocryst Pharmaceuticals (BCRX) Reports First Quarter 2014 Financial Results 5/8/2014 9:32:40 AM